SCHEMBL23219252

SCHEMBL23219252

CCOC(=O)Cc1ccccc1OCc1coc2c1cc(Br)c1oc(C)cc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 1/20 0.39
CFD P00746 1/20 0.37
DUSP3 P51452 1/20 0.37
PTPN5 P54829 1/20 0.37
PTPN11 Q06124 1/20 0.37
CTDSP1 Q9GZU7 1/20 0.37
MAPT P10636 3/20 0.35
TP53 P04637 1/20 0.35
THRB P10828 1/20 0.35
PKM P14618 1/20 0.34
TSHR P16473 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
ALDH1A1 P00352 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33
ALOX5 P09917 2/20 0.33
POLB P06746 1/20 0.33
FFAR4 Q5NUL3 1/20 0.32
KDM4E B2RXH2 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29592062 1.00 TBXAS1 (0.39) TBXAS1CFDDUSP3PTPN5PTPN11
SCHEMBL28736254 0.89 DUSP3 (0.45) CFDDUSP3PTPN5PTPN11CTDSP1
SCHEMBL29591859 0.88 TBXAS1 (0.39) TBXAS1CFDDUSP3PTPN5PTPN11
SCHEMBL23219118 0.88 TBXAS1 (0.39) TBXAS1CFDDUSP3PTPN5PTPN11
SCHEMBL29852603 0.85 TBXAS1 (0.39) TBXAS1CFDDUSP3PTPN5PTPN11
SCHEMBL23219127 0.85 TBXAS1 (0.39) TBXAS1CFDDUSP3PTPN5PTPN11
SCHEMBL23219098 0.85 TBXAS1 (0.40) TBXAS1CFDDUSP3PTPN5PTPN11
SCHEMBL29591267 0.85 TBXAS1 (0.40) TBXAS1CFDDUSP3PTPN5PTPN11
SCHEMBL23218255 0.82 TBXAS1 (0.41) TBXAS1CFDDUSP3PTPN5PTPN11
SCHEMBL29852978 0.82 TBXAS1 (0.41) TBXAS1CFDDUSP3PTPN5PTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4041238-A1 ORAL COMPLEMENT FACTOR D INHIBITORS Biocryst Pharmaceuticals, Inc. (US) 2022-08-17 EP disclosed
CN-114502168-A Oral complement factor D inhibitors 拜奥克里斯特制药公司 2022-05-13 CN disclosed
WO-2021072198-A1 ORAL COMPLEMENT FACTOR D INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2021-04-15 WO disclosed
WO-2021072198-A1 ORAL COMPLEMENT FACTOR D INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2021-04-15 WO disclosed